BG-SOL 0.05%W/W CREAM

Indications

• Psoriasis
• Eczema
• Contact dermatitis
• Seborrheic dermatitis
• Lichen planus
• Nummular dermatitis

Dosage

Children: Refer to the BNF for Children for age-appropriate dosing and guidelines, particularly due to the increased risk of systemic absorption and side effects in children.

Adults: Refer to the BNF for specific dosing instructions, typically applied once or twice daily in a thin layer to the affected area.

Mechanism of action

Clobetasol works by binding to the glucocorticoid receptor, which leads to the regulation of gene expression involved in inflammatory and immune responses. This results in the inhibition of pro-inflammatory cytokines and mediators, thereby reducing inflammation, redness, and itching in affected areas.

Pharmacodynamics

As a potent synthetic corticosteroid, clobetasol exerts anti-inflammatory, antipruritic, and vasoconstrictive effects. Its high affinity for glucocorticoid receptors contributes to its effectiveness in reducing the inflammatory response and alleviating symptoms associated with various dermatological conditions.

Pharmacokinetics

Clobetasol is rapidly absorbed through the skin, with systemic absorption depending on factors such as the formulation (cream, ointment, solution) and the area of application. It undergoes extensive hepatic metabolism, with metabolites excreted primarily in the urine. The half-life varies and is influenced by the formulation and individual patient factors.

Contra-indications

• Hypersensitivity to clobetasol or any component of the formulation
• Untreated bacterial, viral, fungal infections
• Acne vulgaris, rosacea, perioral dermatitis

Adverse effects

• Skin atrophy
• Striae
• Telangiectasia
• Allergic contact dermatitis
• Burning, itching, irritation at the application site
• Systemic effects with prolonged use

Interactions

• May enhance the effects of other topical corticosteroids when used concomitantly
• Caution with other immunosuppressive agents, as they may increase the risk of infections

Precautions

• Use with caution in patients with a history of skin infections
• Not for use in the eyes or on mucous membranes
• Prolonged use should be monitored to prevent systemic absorption and potential adrenal suppression

Pregnancy

Clobetasol is a Category C drug. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Clobetasol may be excreted in breast milk. Caution should be exercised when administering to nursing mothers.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Formulations

• Topical cream
• Topical ointment
• Topical solution